Counseling, Provision Interventions Increase Contraceptive Use
TUESDAY, May 24, 2022 (HealthDay News) — Contraceptive counseling and provision interventions increase contraceptive use without increasing sexually transmitted infections or reducing condom use, according to a systematic review and meta-analysis pub…
Learn MoreRisk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
TUESDAY, May 24, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D) receiving first-line sodium-glucose cotransporter-2 inhibitors (SGLT-2i), the risk for stroke, myocardial infarction (MI), and all-cause mortality is similar to those re…
Learn MoreRisk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
TUESDAY, May 24, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D) receiving first-line sodium-glucose cotransporter-2 inhibitors (SGLT-2i), the risk for stroke, myocardial infarction (MI), and all-cause mortality is similar to those re…
Learn MoreBurden of Persistent Symptoms High After COVID-19 Infection
TUESDAY, May 24, 2022 (HealthDay News) — A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection (PA…
Learn MoreBurden of Persistent Symptoms High After COVID-19 Infection
TUESDAY, May 24, 2022 (HealthDay News) — A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection (PA…
Learn MorePersistent Opioid Use After Sarcoma Treatment Explored Among Youth
TUESDAY, May 24, 2022 (HealthDay News) — Twenty-three percent of adolescents and young adults (AYAs) with sarcoma who were previously opioid-naive and use opioids during treatment have new persistent opioid use after treatment, according to a study p…
Learn MorePersistent Opioid Use After Sarcoma Treatment Explored Among Youth
TUESDAY, May 24, 2022 (HealthDay News) — Twenty-three percent of adolescents and young adults (AYAs) with sarcoma who were previously opioid-naive and use opioids during treatment have new persistent opioid use after treatment, according to a study p…
Learn MoreRisk for VTE Up During Five Years After Prostate Cancer Diagnosis
TUESDAY, May 24, 2022 (HealthDay News) — Men with prostate cancer have an increased risk for venous thromboembolism (VTE) during the five years after cancer diagnosis, according to a study published online May 23 in BMJ Open.Yanina Balabanova, from B…
Learn MoreRisk for VTE Up During Five Years After Prostate Cancer Diagnosis
TUESDAY, May 24, 2022 (HealthDay News) — Men with prostate cancer have an increased risk for venous thromboembolism (VTE) during the five years after cancer diagnosis, according to a study published online May 23 in BMJ Open.Yanina Balabanova, from B…
Learn MoreH. pylori Infection Often Detected in Patients With Dyspepsia
TUESDAY, May 24, 2022 (HealthDay News) — In Northwest Ethiopia, 35 percent of patients with dyspepsia have peptic ulcer disease, with risk factors including Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drug (NSAID)/ace…
Learn More